Cost-effectiveness analysis of smoking-cessation counseling training for physicians and pharmacists

Addictive Behaviors

Volumn 45, Issue , 2015, Pages 79-86

  Cantor, Scott B ^a   Deshmukh, Ashish A ^a   Luca, Nancy Stancic ^b   Nogueras González, Graciela M ^a   Rajan, Tanya ^a   Prokhorov, Alexander V ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b TEXAS WOMAN'S UNIVERSITY   (United States)

Author keywords

Costs and cost analysis; Medical decision making; Nicotine; Smoking cessation

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HUMAN; LIFE EXPECTANCY; MALE; MEDICAL DECISION MAKING; MEDICAL EDUCATION; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT COUNSELING; PHARMACIST; PHYSICIAN; QUALITY ADJUSTED LIFE YEAR; SMOKING CESSATION; SMOKING CESSATION PROGRAM; TOBACCO DEPENDENCE; AGED; CONTINUING EDUCATION; COST BENEFIT ANALYSIS; COUNSELING; ECONOMICS; EDUCATION; PROCEDURES; SMOKING; THERAPY;

ADULT; AGED; COST-BENEFIT ANALYSIS; COUNSELING; EDUCATION, CONTINUING; FEMALE; HUMANS; MALE; MIDDLE AGED; PHARMACISTS; PHYSICIANS; QUALITY-ADJUSTED LIFE YEARS; SMOKING; SMOKING CESSATION;

EID: 84921899725     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2015.01.004     Document Type: Article

References (32)

1. Abelin T., Buehler A., Muller P., Vesanen K., Imhof P.R. Controlled trial of transdermal nicotine patch in tobacco withdrawal. Lancet 1989, 1:7-10.
2. Bauld L., Judge K., Platt S. Assessing the impact of smoking cessation services on reducing health inequalities in England: Observational study. Tobacco Control 2007, 16:400-404.
3. Bolin K., Lindgren B., Willers S. The cost utility of bupropion in smoking cessation health programs: Simulation model results for Sweden. Chest 2006, 129:651-660.
4. Cantor S.B. Decision analysis: Theory and application to medicine. Primary Care; Clinics in Office Practice 1995, 22:261-270.
5. Cantor S.B., Miller L. Time horizon. Encyclopedia of Medical Decision Making 2009, 1138-1139. SAGE Publications, Inc., Thousand Oaks, CA. M. Kattan (Ed.).
6. Cromwell J., Bartosch W.J., Fiore M.C., Hasselblad V., Baker T. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. JAMA 1997, 278:1759-1766.
7. Cummings S.R., Rubin S.M., Oster G. The cost-effectiveness of counseling smokers to quit. JAMA 1989, 261:75-79.
8. Fagerstrom K.O. A comparison of psychological and pharmacological treatment in smoking cessation. Journal of Behavioral Medicine 1982, 5:343-351.
9. Fiore M.C., Bailey W.C., Cohen S.J., et al. for the Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives, A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report. JAMA 2000, 283:3244-3254.
10. Fiscella K., Franks P. Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling. JAMA 1996, 275:1247-1251.
11. Goldberg D.N., Hoffman A.M., Farinha M.F., Marder D.C., Tinson-Mitchem L., Burton D., et al. Physician delivery of smoking-cessation advice based on the stages-of-change model. American Journal of Preventive Medicine 1994, 10:267-274.
12. Hall S.M., Lightwood J.M., Humfleet G.L., Bostrom A., Reus V.I., Munoz R. Cost-effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation. Journal of Behavioral Health Services and Research 2005, 32:381-392.
13. Hjalmarson A.I. Effect of nicotine chewing gum in smoking cessation. A randomized, placebo-controlled, double-blind study. JAMA 1984, 252:2835-2838.
14. Honeycutt A.A., Clayton L., Khavjou O., Finkelstein E.A., Prabhu M., Blitstein J.L., et al. Guide to analyzing the cost-effectiveness of community public health prevention approaches. In 2006, U.S. Department of Health and Human Services, Research Triangle Park, NC.
15. Hurt R.D., Dale L.C., Fredrickson P.A., Caldwell C.C., Lee G.A., Offord K.P., et al. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement. JAMA 1994, 271:595-600.
16. Jarvis M.J., Cohen J.E., Delnevo C.D., Giovino G.A. Dispelling myths about gender differences in smoking cessation: Population data from the USA. Canada and Britain Tobacco Control 2013, 22:356-360.
17. Kottke T.E., Brekke M.L., Solberg L.I., Hughes J.R. A randomized trial to increase smoking intervention by physicians. Doctors Helping Smokers, Round I. JAMA 1989, 261:2101-2106.
18. Lipscomb J., Weinstein M.C., Torrance G.W. Time preference. Cost-effectiveness in Health and Medicine 1996, 214-235. Oxford University Press, New York. M.R. Gold, J.E. Siegel, L.B. Russel, M.C. Weinstein (Eds.).
19. Luce B.R., Manning W.G., Siegel J.E., Lipscomb J. Estimating costs in cost-effectiveness analysis. Cost-effectiveness in Health and Medicine 1996, 194. Oxford University Press, New York. M.R. Gold, J.E. Siegel, L.B. Russel, M.C. Weinstein (Eds.).
20. McCarney R., Warner J., Iliffe S., van Haselen R., Griffin M., Fisher P. The Hawthorne effect: A randomised, controlled trial. BMC Medical Research Methodology 2007, 7:30.
21. Ockene J.K., Hosmer D.W., Williams J.W., Goldberg R.J., Ockene I.S., Biliouris T., et al. The relationship of patient characteristics to physician delivery of advice to stop smoking. Journal of General Internal Medicine 1987, 2:337-340.
22. Ockene J.K., Lindsay E.A., Hymowitz N., Giffen C., Purcell T., Pomrehn P., et al. Tobacco control activities of primary-care physicians in the community intervention trial for smoking cessation. COMMIT Research Group. Tobacco Control 1997, 6(Suppl. 2):S49-S56.
23. Pinget C., Martin E., Wasserfallen J.B., Humair J.P., Cornuz J. Cost-effectiveness analysis of a European primary-care physician training in smoking cessation counseling. European Journal of Cardiovascular Prevention and Rehabilitation 2007, 14:451-455.
24. Prokhorov A.V., Hudmon K.S., Marani S., Foxhall L., Ford K.H., Luca N.S., et al. Engaging physicians and pharmacists in providing smoking cessation counseling. Archives of Internal Medicine 2010, 170:1640-1646.
25. Richmond R., Mendelsohn C., Kehoe L. Family physicians' utilization of a brief smoking cessation program following reinforcement contact after training: A randomized trial. Preventive Medicine 1998, 27:77-83.
26. Rogers R.G., Hummer R.A., Krueger P.M., Pampel F.C. Mortality attributable to cigarette smoking in the United States. Population and Development Review 2005, 31:259-292.
27. Sonnenberg F.A., Beck J.R. Markov models in medical decision making: A practical guide. Medical Decision Making 1993, 13:322-338.
28. Stead L.F., Buitrago D., Preciado N., Sanchez G., Hartmann-Boyce J., Lancaster T. Physician advice for smoking cessation. Cochrane Database of Systematic Reviews 2013, 5. (CD000165).
29. Trudeau T. The Hawthorne study revisited. Hospital topics 1982, 60:17.
30. Velicer W.F., Prochaska J.O., Rossi J.S., Snow M.G. Assessing outcome in smoking cessation studies. Psychological Bulletin 1992, 111:23-41.
31. Weinstein M.C. How much are Americans willing to pay for a quality-adjusted life year?. Medical Care 2008, 46:343-345.
32. Zhu S.H., Anderson C.M., Tedeschi G.J., Rosbrook B., Johnson C.E., Byrd M., et al. Evidence of real-world effectiveness of a telephone quitline for smokers. New England Journal of Medicine 2002, 347:1087-1093.